Peptide Comparison

Sermorelin vs Tesamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research.

Sermorelin and Tesamorelin are both GHRH (Growth Hormone Releasing Hormone) analogs that stimulate natural growth hormone production. Tesamorelin is FDA-approved for HIV-related lipodystrophy, while Sermorelin was previously FDA-approved and remains widely used. They work similarly but have different regulatory statuses and some clinical differences.

Quick Comparison

Aspect

Sermorelin

Tesamorelin

FDA Status

Previously approved, now used off-label

FDA-approved for HIV lipodystrophy

Structure

GHRH (1-29) - shorter fragment

Modified GHRH - trans-3-hexenoic acid added

Half-Life

~10-20 minutes

~26-38 minutes

Primary Use

Anti-aging, GH deficiency, general wellness

Visceral fat reduction (FDA use)

Fat Loss Data

Indirect through GH elevation

15-18% visceral fat reduction in trials

Dosing

100-300 mcg daily or 2x daily

2 mg daily (FDA dose)

Cost

Generally less expensive

More expensive (patented)

Clinical Data

Historical FDA data, clinic use

Recent extensive Phase 3 trials

Key Similarities

Both stimulate natural GH release
Both are GHRH analogs (same mechanism)
Both preserve pituitary function
Both require functioning pituitary
Both can improve body composition
Both typically used daily
Both work synergistically with GHRPs

Key Differences

Tesamorelin has current FDA approval
Tesamorelin has more recent clinical trial data
Sermorelin is less expensive
Tesamorelin specifically studied for visceral fat
Sermorelin shorter half-life (more injections may help)
Tesamorelin dose is standardized; Sermorelin varies
Sermorelin has longer clinical history

When to Choose Each

Choose Sermorelin

Choose Sermorelin for cost-effective GH stimulation, anti-aging protocols, or when combining with GHRPs for synergistic effects. Well-established with decades of clinical use, it remains effective for general GH optimization.

Choose Tesamorelin

Choose Tesamorelin if visceral fat reduction is the primary goal, you want the most recent FDA-approved option, or you're willing to pay more for standardized clinical dosing. Best validated for abdominal fat specifically.

Can You Stack Them?

Neither should be combined with each other—they work on the same pathway. Both can be combined with GHRPs (like Ipamorelin) for synergistic GH release. Choose one GHRH and potentially add a GHRP.

Frequently Asked Questions

Both work well for anti-aging through GH stimulation. Sermorelin is more commonly used due to cost and history. Tesamorelin has better fat loss data if that's the primary concern.

Tesamorelin is patented and FDA-approved, making it more expensive than Sermorelin. The extensive Phase 3 trial data also factors into cost.

Protocols vary. Some use cycling (12 weeks on, 4 weeks off), others use continuously. Unlike HGH, these preserve pituitary function, but breaks may maintain sensitivity.

References

Walker RF. "Sermorelin clinical use." Clin Interv Aging, 2006. PMID: 18046878
Falutz J, et al. "Tesamorelin fat reduction." JAMA, 2007. PMID: 17785649

Get the Complete Comparison Guide

Download our detailed comparison charts and decision framework.